课题基金 / 基金详情

The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada

The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada
价格上限对加拿大仿制药行业和省级药物计划成本的影响
批准号：
238754
负责人：
Anis Aslam H
金额：
$8.4万
依托单位：
St. Paul's Hospital, Vancouver
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=238754&lang=en
关键词：
Competition Generic Drugs Health Economics Health Policy Patent Protection Pharmaceutical Policy Pharmaceuticals Price

项目摘要

项目成果

Anis Aslam H的其他基金

相似基金

相关文献

中文摘要
翻译
自2010年以来，加拿大的几个省级政府已经宣布降低仿制药的最高价格，设定了新的价格上限，占品牌药品价格的百分比。尽管它们很受欢迎，但有证据表明，c价
英文摘要
Since 2010, several provincial governments in Canada have announced reductions in the maximum price of generic drugs, setting new price caps as a percentage of the price of the branded drug product. Despite their popularity, evidence suggests that price c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating and Informing Canada's Proposed Pharmaceutical Price Regulations
CIHR Clinical Trials Network in HIV/AIDS
  • 批准号：
    392040
  • 项目类别：
    Directed Grant
  • 资助金额：
    $1664.62万
  • 财政年份：
    2018
  • 负责人：
    Anis Aslam H
  • 依托单位：
    St. Paul's Hospital, Vancouver
Sharing the CIHR Canadian HIV Trials Network's Experience With Community-Investigator Collaborations: AIDS 2018 - Amsterdam, Netherlands
  • 批准号：
    383703
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.45万
  • 财政年份：
    2018
  • 负责人：
    Anis Aslam H
  • 依托单位：
    University of British Columbia
The pricing of generic drugs and its impact on market structure, competitiveness and security of supply
海外基金